---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-26-000069"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T18:52:04.216650+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Clover Health publishes supplemental Q&A re Q4 2025 earnings

## Summary
- Filed under Item 7.01; responses to frequently asked questions from shareholders.
- Document is furnished as Exhibit 99.1; available on investor relations page.
- No new financial results or guidance disclosed in the 8-K filing body.

## SEC filing metadata
- accession: 0001801170-26-000069
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000069/0001801170-26-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000069/clov-20260306.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-26-000069
- JSON: https://secwatch.observer/filing/0001801170-26-000069.json
- Plain text: https://secwatch.observer/filing/0001801170-26-000069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.